T-cell/histiocyte-rich large B-cell lymphoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Concurrent Development of B-Cell Lymphoblastic Lymphoma and Histiocytic Sarcoma in a C57BL/6 Laboratory Mouse: A Case Report.Veterinary medicine and science · 2026
   Article
2. An Unusual Presentation of T-cell/Histiocyte-Rich B-cell Lymphoma: A Diagnostic Challenge.Cureus · 2025
   Article
3. Pediatric T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (THRLBC) in an 8-Year-Old Male Child: A Case Report.Case reports in oncological medicine · 2025
   Article
4. Catch the Calcium: T-Cell Histiocyte-Rich B-Cell Lymphoma Presenting as Hypercalcemia.World journal of oncology · 2023
   Article
5. Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma.Life (Basel, Switzerland) · 2023
   Review
6. Primary splenic T-cell/histiocyte-rich B-cell lymphoma in a patient with recurrent hairy cell leukemia: a case report.Oxford medical case reports · 2022
   Article
7. The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade.Blood advances · 2022
   Article
8. Splenic Micronodular T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis.Acta haematologica · 2022
   Review
9. Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia-telangiectasia caused by novel compound heterozygous variants in ATM.International journal of hematology · 2021
   Article
10. Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.Blood · 2021
    Article
11. Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.Leukemia & lymphoma · 2019
    Article
12. Diagnosis of Hodgkin lymphoma in the modern era.British journal of haematology · 2019
    Review
13. T-cell/histiocyte-rich large B-cell lymphoma in a child: A case report and review of literature.World journal of clinical cases · 2018
    Article
14. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.World journal of gastroenterology · 2017
    Review
15. The histological classification of diffuse large B-cell lymphomas.Seminars in hematology · 2015
    Review
16. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.The Journal of clinical investigation · 2015
    Article
17. First case of T-cell/histiocyte-rich-large B-cell lymphoma presenting with duodenal obstruction.The Libyan journal of medicine · 2013
    Article
18. Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.Hematology. American Society of Hematology. Education Program · 2011
    Review
19. The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.Cancer journal (Sudbury, Mass.)
    Review

Corrections and comments

• Comment on
  T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.2010

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as